Subsidiary Guarantors for 2036 Notes Subsidiary Guarantors for 2036 Notes (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 27, 2017	Jan. 29, 2016	Oct. 28, 2016	Oct. 30, 2015
Condensed Consolidating Statement of Income
Net sales	$ 497,769	$ 526,300
Cost of sales	389,108	438,256
Product development, selling and administrative expenses	111,111	110,413
Restructuring expenses	772	26,659
Other income	(1,472)	(3,941)
Operating loss	(1,750)	(45,087)
Intercompany items	0	0
Interest (expense) income, net	(11,022)	(12,116)
Loss before income taxes	(12,772)	(57,203)
(Benefit) income for income taxes	(12,495)	(16,982)
Equity in (loss) income of subsidiaries	0	0
Net loss	(277)	(40,221)
Comprehensive (loss) income	(2,899)	(72,584)
Current assets:
Cash and cash equivalents	321,909		$ 276,709
Accounts receivable, net	639,881		683,958
Inventories	836,465		814,821
Other current assets	133,005		113,434
Assets held for sale	330		3,703
Total current assets	1,931,590		1,892,625
Property, plant and equipment, net	642,882		656,245
Other assets:
Other intangible assets, net	217,081		223,411
Goodwill	350,762		350,843
Deferred income taxes	179,539		171,775
Other non-current assets	123,650		128,401
Total other assets	871,032		874,430
Total assets	3,445,504		3,423,300
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	43,006		41,611
Trade accounts payable	219,502		236,787
Employee compensation and benefits	72,532		91,224
Advance payments and progress billings	242,450		173,121
Accrued warranties	40,775	50,518	40,787	$ 52,146
Other accrued liabilities	167,657		188,591
Total current liabilities	785,922		772,121
Long-term obligations	953,241		962,291
Other liabilities:
Liabilities for postretirement benefits	14,249		14,260
Accrued pension costs	169,471		175,120
Other non-current liabilities	127,930		117,802
Total other liabilities	311,650		307,182
Shareholders’ equity	1,394,691		1,381,706
Total liabilities and shareholders’ equity	3,445,504		3,423,300
Operating Activities:
Net cash provided (used) by operating activities	41,473	108,589
Investing Activities:
Property, plant and equipment acquired	(6,611)	(8,103)
Proceeds from sale of property, plant and equipment	4,900	9,167
Other investing activities, net	0	122
Net cash (used) provided by investing activities	(1,711)	1,186
Financing Activities:
Common stock issued	10,668	0
Dividends paid	(1,009)	(997)
Repayments of term loan	(9,375)	(4,687)
Payments on credit agreement	0	(58,600)
Financing fees	0	(1,011)
Other financing activities, net	5,284	(1,507)
Net cash provided (used) by financing activities	5,568	(66,802)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	(60)	(5,925)
Increase in Cash, Cash Equivalents and Restricted Cash	45,270	37,048
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	278,219	102,885
Cash, Cash Equivalents and Restricted Cash at End of Period	323,489	139,933
6.625% Senior Notes due 2036 | Reportable Legal Entities | Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0
Cost of sales	0	0
Product development, selling and administrative expenses	12,089	7,380
Restructuring expenses	0	395
Other income	0	0
Operating loss	(12,089)	(7,775)
Intercompany items	(14,809)	15,148
Interest (expense) income, net	12,522	(12,720)
Loss before income taxes	(14,376)	(5,347)
(Benefit) income for income taxes	(10,370)	(11,505)
Equity in (loss) income of subsidiaries	3,729	(46,379)
Net loss	(277)	(40,221)
Comprehensive (loss) income	(2,899)	(72,584)
Current assets:
Cash and cash equivalents	134,757		131,344
Accounts receivable, net	0		3
Inventories	0		0
Other current assets	64,567		5,975
Assets held for sale	0		0
Total current assets	199,324		137,322
Property, plant and equipment, net	17,904		18,521
Other assets:
Other intangible assets, net	0		0
Goodwill	0		0
Deferred income taxes	123,068		154,267
Other non-current assets	2,321,894		2,351,030
Total other assets	2,444,962		2,505,297
Total assets	2,662,190		2,661,140
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	37,057		37,057
Trade accounts payable	2,157		4,013
Employee compensation and benefits	10,311		8,346
Advance payments and progress billings	0		0
Accrued warranties	0		0
Other accrued liabilities	93,581		87,958
Total current liabilities	143,106		137,374
Long-term obligations	953,194		962,251
Other liabilities:
Liabilities for postretirement benefits	14,249		14,260
Accrued pension costs	169,471		175,120
Other non-current liabilities	(10,821)		(9,571)
Total other liabilities	172,899		179,809
Shareholders’ equity	1,392,991		1,381,706
Total liabilities and shareholders’ equity	2,662,190		2,661,140
Operating Activities:
Net cash provided (used) by operating activities	(1,267)	86,203
Investing Activities:
Property, plant and equipment acquired	(99)	(240)
Proceeds from sale of property, plant and equipment	0	0
Other investing activities, net		(7)
Net cash (used) provided by investing activities	(99)	(247)
Financing Activities:
Common stock issued	10,668
Dividends paid	(1,009)	(997)
Repayments of term loan	(9,375)	(4,687)
Payments on credit agreement		(58,600)
Financing fees		(1,011)
Other financing activities, net	3,740	0
Net cash provided (used) by financing activities	4,024	(65,295)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	0	0
Increase in Cash, Cash Equivalents and Restricted Cash	2,658	20,661
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	132,099	581
Cash, Cash Equivalents and Restricted Cash at End of Period	134,757	21,242
6.625% Senior Notes due 2036 | Reportable Legal Entities | Supplemental Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	259,530	265,429
Cost of sales	202,453	234,709
Product development, selling and administrative expenses	46,733	40,680
Restructuring expenses	357	20,016
Other income	620	(698)
Operating loss	9,367	(29,278)
Intercompany items	(28,881)	(47,734)
Interest (expense) income, net	707	248
Loss before income taxes	(18,807)	(76,764)
(Benefit) income for income taxes	3,642	150
Equity in (loss) income of subsidiaries	10,477	17,493
Net loss	(11,972)	(59,421)
Comprehensive (loss) income	(12,415)	(60,701)
Current assets:
Cash and cash equivalents	63,716		21,476
Accounts receivable, net	175,444		186,332
Inventories	386,740		377,875
Other current assets	6,203		5,996
Assets held for sale	330		3,703
Total current assets	632,433		595,382
Property, plant and equipment, net	208,661		214,488
Other assets:
Other intangible assets, net	176,196		187,018
Goodwill	341,984		341,984
Deferred income taxes	0		0
Other non-current assets	2,397,239		1,864,321
Total other assets	2,915,419		2,393,323
Total assets	3,756,513		3,203,193
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0		0
Trade accounts payable	88,413		80,848
Employee compensation and benefits	17,436		28,363
Advance payments and progress billings	120,785		69,174
Accrued warranties	17,239		16,909
Other accrued liabilities	35,144		38,376
Total current liabilities	279,017		233,670
Long-term obligations	0		0
Other liabilities:
Liabilities for postretirement benefits	0		0
Accrued pension costs	0		0
Other non-current liabilities	9,537		9,832
Total other liabilities	9,537		9,832
Shareholders’ equity	3,467,959		2,959,691
Total liabilities and shareholders’ equity	3,756,513		3,203,193
Operating Activities:
Net cash provided (used) by operating activities	(15,033)	(4,564)
Investing Activities:
Property, plant and equipment acquired	(1,273)	(1,666)
Proceeds from sale of property, plant and equipment	642	6,789
Other investing activities, net		0
Net cash (used) provided by investing activities	(631)	5,123
Financing Activities:
Common stock issued	0
Dividends paid	0	0
Repayments of term loan	0	0
Payments on credit agreement		0
Financing fees		0
Other financing activities, net	13	0
Net cash provided (used) by financing activities	13	0
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	0	0
Increase in Cash, Cash Equivalents and Restricted Cash	(15,651)	559
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	79,367	2,008
Cash, Cash Equivalents and Restricted Cash at End of Period	63,716	2,567
6.625% Senior Notes due 2036 | Reportable Legal Entities | Supplemental Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	387,137	388,918
Cost of sales	302,606	307,630
Product development, selling and administrative expenses	52,289	62,353
Restructuring expenses	415	6,248
Other income	(2,092)	(3,243)
Operating loss	33,919	15,930
Intercompany items	4,007	(6,071)
Interest (expense) income, net	(24,251)	356
Loss before income taxes	13,675	10,215
(Benefit) income for income taxes	(5,767)	(5,627)
Equity in (loss) income of subsidiaries	0	0
Net loss	19,442	15,842
Comprehensive (loss) income	14,778	(15,434)
Current assets:
Cash and cash equivalents	123,436		123,889
Accounts receivable, net	472,845		515,418
Inventories	516,976		502,162
Other current assets	62,235		101,463
Assets held for sale	0		0
Total current assets	1,175,492		1,242,932
Property, plant and equipment, net	420,611		427,645
Other assets:
Other intangible assets, net	40,885		36,393
Goodwill	8,778		8,859
Deferred income taxes	56,471		17,508
Other non-current assets	4,254,068		3,049,371
Total other assets	4,360,202		3,112,131
Total assets	5,956,305		4,782,708
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	5,949		4,554
Trade accounts payable	128,932		151,926
Employee compensation and benefits	44,785		54,515
Advance payments and progress billings	133,932		104,427
Accrued warranties	23,536		23,878
Other accrued liabilities	44,508		67,801
Total current liabilities	381,642		407,101
Long-term obligations	47		40
Other liabilities:
Liabilities for postretirement benefits	0		0
Accrued pension costs	0		0
Other non-current liabilities	129,214		117,541
Total other liabilities	129,214		117,541
Shareholders’ equity	5,445,402		4,258,026
Total liabilities and shareholders’ equity	5,956,305		4,782,708
Operating Activities:
Net cash provided (used) by operating activities	57,773	26,950
Investing Activities:
Property, plant and equipment acquired	(5,239)	(6,197)
Proceeds from sale of property, plant and equipment	4,258	2,378
Other investing activities, net		129
Net cash (used) provided by investing activities	(981)	(3,690)
Financing Activities:
Common stock issued	0
Dividends paid	0	0
Repayments of term loan	0	0
Payments on credit agreement		0
Financing fees		0
Other financing activities, net	1,531	(1,507)
Net cash provided (used) by financing activities	1,531	(1,507)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	(60)	(5,925)
Increase in Cash, Cash Equivalents and Restricted Cash	58,263	15,828
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	66,753	100,296
Cash, Cash Equivalents and Restricted Cash at End of Period	125,016	116,124
6.625% Senior Notes due 2036 | Eliminations
Condensed Consolidating Statement of Income
Net sales	(148,898)	(128,047)
Cost of sales	(115,951)	(104,083)
Product development, selling and administrative expenses	0	0
Restructuring expenses	0	0
Other income	0	0
Operating loss	(32,947)	(23,964)
Intercompany items	39,683	38,657
Interest (expense) income, net	0	0
Loss before income taxes	6,736	14,693
(Benefit) income for income taxes	0	0
Equity in (loss) income of subsidiaries	(14,206)	28,886
Net loss	(7,470)	43,579
Comprehensive (loss) income	(2,363)	$ 76,135
Current assets:
Cash and cash equivalents	0		0
Accounts receivable, net	(8,408)		(17,795)
Inventories	(67,251)		(65,216)
Other current assets	0		0
Assets held for sale	0		0
Total current assets	(75,659)		(83,011)
Property, plant and equipment, net	(4,294)		(4,409)
Other assets:
Other intangible assets, net	0		0
Goodwill	0		0
Deferred income taxes	0		0
Other non-current assets	(8,849,551)		(7,136,321)
Total other assets	(8,849,551)		(7,136,321)
Total assets	(8,929,504)		(7,223,741)
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0		0
Trade accounts payable	0		0
Employee compensation and benefits	0		0
Advance payments and progress billings	(12,267)		(480)
Accrued warranties	0		0
Other accrued liabilities	(5,576)		(5,544)
Total current liabilities	(17,843)		(6,024)
Long-term obligations	0		0
Other liabilities:
Liabilities for postretirement benefits	0		0
Accrued pension costs	0		0
Other non-current liabilities	0		0
Total other liabilities	0		0
Shareholders’ equity	(8,911,661)		(7,217,717)
Total liabilities and shareholders’ equity	$ (8,929,504)		$ (7,223,741)